- Home
- RVNC vs FORM Comparison
RVNC vs FORM Comparison
Compare RVNC & FORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- FORM
- Stock Information
- Founded
- RVNC 1999
- FORM 1993
- Country
- RVNC United States
- FORM United States
- Employees
- RVNC N/A
- FORM N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- FORM Semiconductors
- Sector
- RVNC Health Care
- FORM Technology
- Exchange
- RVNC Nasdaq
- FORM Nasdaq
- Market Cap
- RVNC 320.5M
- FORM 3.0B
- IPO Year
- RVNC 2014
- FORM N/A
- Fundamental
- Price
- RVNC $3.09
- FORM $42.88
- Analyst Decision
- RVNC Hold
- FORM Buy
- Analyst Count
- RVNC 9
- FORM 8
- Target Price
- RVNC $8.45
- FORM $55.38
- AVG Volume (30 Days)
- RVNC 3.6M
- FORM 897.2K
- Earning Date
- RVNC 11-07-2024
- FORM 02-05-2025
- Dividend Yield
- RVNC N/A
- FORM N/A
- EPS Growth
- RVNC N/A
- FORM N/A
- EPS
- RVNC N/A
- FORM 1.72
- Revenue
- RVNC $256,945,000.00
- FORM $742,279,000.00
- Revenue This Year
- RVNC $11.28
- FORM $17.59
- Revenue Next Year
- RVNC $27.21
- FORM $8.39
- P/E Ratio
- RVNC N/A
- FORM $24.89
- Revenue Growth
- RVNC 25.82
- FORM 12.31
- 52 Week Low
- RVNC $2.30
- FORM $37.21
- 52 Week High
- RVNC $9.75
- FORM $63.63
- Technical
- Relative Strength Index (RSI)
- RVNC 33.47
- FORM 52.33
- Support Level
- RVNC $3.06
- FORM $41.93
- Resistance Level
- RVNC $3.09
- FORM $50.79
- Average True Range (ATR)
- RVNC 0.11
- FORM 2.14
- MACD
- RVNC 0.02
- FORM 0.17
- Stochastic Oscillator
- RVNC 6.90
- FORM 22.53
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About FORM FormFactor Inc. FormFactor Inc.
FormFactor Inc designs, develops, manufactures, sells, and supports semiconductor probe card products. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.